ChromaDex Acquires Second Pterostilbene Skin Care Patent
The acquisition brings the company’s total number of pterostilbene-related patents to eight.
ChromaDex Corp. (Irvine, CA) has obtained an eighth patent for its pTeroPure pterostilbene. The pterostilbene ingredient is a nature-identical form of this antioxidant found in blueberries. Chromadex now has worldwide pharmaceutical and cosmetic rights to use blueberry-sourced topical pterostilbene for prevention and/or treatment of skin diseases, damage, or injuries-including those relating to aging and exposure to the sun.
The patent marks the company’s second patent for pterostilbene and skin care. In September 2011, Chromadex came to terms with the University of California Irvine for exclusive rights to a different, joint patent.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
